Beijing Wantai Biological Pharmacy Enterprise Co Ltd

603392

Company Profile

  • Business description

    Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.

  • Contact

    No. 31, Science Park Road
    Changping District
    Beijing102206
    CHN

    T: +86 1059528888

    https://www.ystwt.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    3,790

Stocks News & Analysis

stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.
stocks

Major ASX listed miners overvalued

We’ve adjusted our fair values after updating our commodity price assumptions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,138.6019.70-0.22%
CAC 408,062.5849.44-0.61%
DAX 4024,703.12255.94-1.03%
Dow JONES (US)48,497.96861.37-1.75%
FTSE 10010,126.7868.57-0.67%
HKSE26,487.5176.39-0.29%
NASDAQ22,986.21529.18-2.25%
Nikkei 22552,991.10592.47-1.11%
NZX 50 Index13,573.936.36-0.05%
S&P 5006,804.00136.01-1.96%
S&P/ASX 2008,815.9020.70-0.23%
SSE Composite Index4,113.650.35-0.01%

Market Movers